XTNT Stock Analysis: Buy, Sell, or Hold?
XTNT - Xtant Medical Holdings, Inc.
$0.43
0.00 (0.54%)
▲
5d:
-4.49%
30d:
-10.46%
90d:
-23.25%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When XTNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: XTNT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: XTNT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: XTNT is currently trading at $0.43, which is considered oversold relative to its 30-day fair value range of $0.44 to $0.47. From a valuation perspective, the stock is trading at a discount (Forward PE: -85.5) compared to its historical average (65.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, XTNT is in a strong downtrend. The price is currently testing key support at $0.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.23 (+188.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, XTNT is in a strong downtrend. The price is currently testing key support at $0.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $1.23 (+188.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.44 -
$0.47
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 188.5% below Wall St target ($1.23)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$0.44 -
$0.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.44
Resistance Level
$0.48
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-85.50
Wall Street Target
$1.23
(+188.5%)
Revenue Growth (YoY)
-36.5%
Profit Margin
1.5%
PE vs Historical
-85.5 vs 65.2
CHEAP
Share & Embed Analysis
Last updated: June 24, 2026 3:42 PM ET
Data refreshes hourly during market hours. Next update: 4:42 PM
Data refreshes hourly during market hours. Next update: 4:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTNT showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 61 BUY |
